Skip to main content

Call for papers - Substance abuse and comorbid psychiatric disorders

Guest Editors

Carsten Hjorthøj, PhD, Copenhagen Research Center for Mental Health and University of Copenhagen, Denmark
Abhijit Nadkarni, MBBS, DPM, MRCPsych, MSc, PhD, London School of Hygiene and Tropical Medicine, UK
Laura Orsolini, MD, MSc, Polytechnic University of Marche, Italy
Ti-Fei Yuan, PhD, Shanghai Jiao Tong University School of Medicine, China

Submission Status: Open   |   Submission Deadline: 28 November 2024

This Collection spotlights innovative research on substance abuse and comorbid psychiatric disorders, aiming to advance our understanding of the complex interrelationships between these conditions. We invite submissions that explore the epidemiology, underlying factors contributing to comorbidity, and treatment approaches with the goal of informing integrated care strategies and improving outcomes for individuals with dual diagnoses.


New Content ItemThis Collection supports and amplifies research related to SDG 3: Good Health & Wellbeing.

Meet the Guest Editors

Back to top

Carsten Hjorthøj, PhD, Copenhagen Research Center for Mental Health and University of Copenhagen, Denmark

Dr Carsten Hjorthøj is an Associate Professor of Epidemiology in the Department of Public Health at the University of Copenhagen and a research leader of the Copenhagen Research Center for Mental Health.

Dr Hjorthøj has conducted a range of high-quality epidemiological studies within the nationwide Danish registers on cannabis and other substance use in relation to psychiatric disorders, allowing for a complete elimination of the risk of selection bias present in most other studies. Based on these studies, the scientific community now has much stronger indications on the bidirectional and increasing associations between substance use and schizophrenia; the poor prognosis related to substance use, including highly increased mortality; and the overlooked area of substance-induced psychosis.

In addition to this, Dr Hjorthøj's research focuses on improving treatment for some of the most severely affected psychiatric populations in Denmark who are often completely overlooked, including dual diagnosis patients, patients suffering from homelessness, and other marginalized populations.

Abhijit Nadkarni, MBBS, DPM, MRCPsych, MSc, PhD, London School of Hygiene and Tropical Medicine, UK

Dr Abhijit Nadkarni is a NIHR Professor of Global Research at the London School of Hygiene and Tropical Medicine (LSHTM). He is an addiction psychiatrist and global mental health researcher conducting research aimed at developing and evaluating interventions for increasing access to mental healthcare in low resource settings. His host institution in India is Sangath, a mental health research NGO, where he is the Director of the Addictions and Related Research Group.

He is actively involved in the capacity building of mental health researchers and lay health workers in India and overseas, including Nepal, Kenya, and Uganda. He teaches on various MSc courses at the LSHTM and serves as the Course Director for the annual short course on Leadership in Mental Health.

Dr Nadkarni is on the State Mental Health Authority for Goa, State Mental Health Policy drafting committee for Maharashtra, and served on the task force of the Ministry of Health and Family Welfare that developed the mental health operational guidelines for the Ayushman Bharat Program.

Laura Orsolini, MD, MSc, Polytechnic University of Marche, Italy

Dr Laura Orsolini is an Assistant Professor of Psychiatry in the Department of Experimental and Clinical Neurosciences at the Polytechnic University of Marche.

Her main research interests include novel psychoactive substances, new addictions (e.g., web-based psychopathologies, behavioral addictions), youth mental health, digital psychiatry, and psychopharmacology.

Dr Orsolini serves as the Secretary of the European Psychiatric Association (EPA) section on Digital Psychiatry, Committee Member of the EPA section on Addictive Behaviours, Board Member for the International Society for Addiction Medicine's New Professionals Exploration, Training & Education committee, among others. She also serves as an Editorial Board Member for BMC Psychiatry.

Ti-Fei Yuan, PhD, Shanghai Jiao Tong University School of Medicine, China

Dr Ti-Fei Yuan is a Professor of Psychiatry at the Shanghai Mental Health Center, affiliated with the Shanghai Jiao Tong University School of Medicine.

His research focused on neural mechanism of drug addiction and brain stimulation based treatment for psychiatric disorders. Combining animal models and clinical approaches, Dr Yuan explores the neurophysiological changes and cognitive mechanisms underlying addiction. Based on the circuitry and brain plasticity findings, he works to develops targeted brain stimulation therapy using magnetic, electrical, and ultrasound based techniques.

About the Collection

BMC Psychiatry welcomes submissions to a Collection on Substance abuse and comorbid psychiatric disorders.

Substance abuse and comorbid psychiatric disorders represent a complex and challenging area within the field of mental health. Individuals with substance abuse disorders often experience co-occurring psychiatric conditions, and vice versa, leading to significant clinical and public health implications. Understanding the interplay between substance use, abuse, and psychiatric disorders is crucial for developing effective interventions and treatment strategies that address the unique needs of this population.

Continued advancement in our collective understanding of substance abuse and comorbid psychiatric disorders is essential to inform evidence-based interventions and policies. Recent advances have highlighted the intricate relationship between substance use, abuse, and psychiatric disorders, emphasizing the need for integrated care approaches that address both conditions simultaneously. Additionally, research has underscored the role of environmental stressors, genetic vulnerability, and individual personality traits in the development and progression of comorbid substance abuse and psychiatric problems.

Looking ahead, ongoing research in this area holds the potential for identifying novel treatment modalities that target the complex interplay between substance abuse and psychiatric disorders. Future advances may also focus on developing personalized interventions that consider the unique biological, psychological, and social factors contributing to comorbidity, ultimately improving outcomes for individuals with dual diagnoses.

Topics of interest include, but are not limited to:

  • Epidemiology of substance abuse and comorbid psychiatric disorders
  • Genetic and environmental influences on comorbidity
  • Neurobiological mechanisms underlying comorbidity
  • Trauma and its impact on substance abuse and psychiatric disorders
  • Integrated treatment approaches
  • Psychosocial interventions for dual diagnoses
  • Pharmacological interventions for dual diagnoses
  • Technology-based interventions for managing dual diagnoses
  • Health disparities and access to care for individuals with dual diagnoses
  • Dual diagnoses in individuals from low- or middle-income countries, racial or ethnic minority groups, or other marginalized populations


Image credit: KatarzynaBialasiewicz / Getty Images / iStock

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Substance abuse and comorbid psychiatric disorders" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.